Promaxo

📍 Oakland, United States🗓 Founded 2016👥 56 employees💰 Last funded Feb 2024
With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. In March 2021, the company received 510(k) clearance from the U.S. FDA for its revolutionary office-based MRI system, allowing practices and hospitals to seamlessly guide prostate interventions under the single-sided scanner. Send inquiries to: hello@promaxo.com
6
Total investors
1
Early stage
2
Mid stage
3
Late stage
2016
Founded
Investor geography1 country
United States
5
Investor activity2017–2024 · investors recorded per year
2017120192202212023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Promaxo?
Promaxo has 6 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage and 3 late-stage investors.
When did Promaxo last raise funding?
The most recent investment in Promaxo recorded on gritt.io was in February 2024.
When was Promaxo founded?
Promaxo was founded in 2016.
What industry is Promaxo in?
Promaxo operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Promaxo based?
Promaxo is headquartered in Oakland, United States.